Sorting Nexin 12 (SNX12) Peptid
SNX12
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle SNX12 Produkte
- SNX12 (Sorting Nexin 12 (SNX12))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- SNX12 peptide corresponds to 13 amino acids of SNX12.
-
-
- Applikationshinweise
- SNX12 Peptide is used for blocking the activity of SNX12 antibody . The SNX12 antibody ships at 0.5 mg/mL and the SNX12 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- SNX12 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- SNX12 (Sorting Nexin 12 (SNX12))
- Synonyme
- fc02c04 Peptide, fc03c06 Peptide, fj97e07 Peptide, wu:fc02c04 Peptide, wu:fc03c06 Peptide, wu:fj97e07 Peptide, zgc:158590 Peptide, zgc:55728 Peptide, zgc:77034 Peptide, Grd19 Peptide, sdp3 Peptide, snx12 Peptide, snx3a Peptide, SNX12 Peptide, LOC100229938 Peptide, 2610001F05Rik Peptide, AW045757 Peptide, SDP8 Peptide, RGD1565585 Peptide, sorting nexin 12 Peptide, sorting nexin 3 Peptide, Sorting nexin 12 Peptide, sorting nexin-12 Peptide, snx12 Peptide, snx3 Peptide, SNX12 Peptide, Bm1_26490 Peptide, LOAG_13370 Peptide, Snx12 Peptide
- Gen-ID
- 29934
- NCBI Accession
- NP_037478
- OMIM
- 23111030
- UniProt
- Q9UMY4
-
Sie sind hier:
